Abstract Patient-derived tumoroids have emerged as promising models for evaluating patient-specific responses to anti-cancer therapies, yet their clinical adoption remains limited. While the reasons for this limited implementation are not fully elucidated, several are known and can be addressed...
- Forfattere
- Baard Cristoffer. Sakshaug
- Tonje Husby Haukaas
- Emma Evelina Folkesson
- Christa Ringers
- Henri C.H. Bwanika
- Ingrid A. Bergstrøm
- Margrét Sylvía Sigfúsdóttir
- Hanne Hein Trøen
- Sigri Bakken Sperstad
- Tore Stornes
- Geir Klinkenberg
- Torkild Visnes
- Åsmund Flobak
- År
- 2026
- Type
- Vitenskapelig artikkel